# Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis

> **NCT01656226** · PHASE4 · UNKNOWN · sponsor: **ISDIN** · enrollment: 50 (estimated)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DEVICE:** Eryfotona AK-NMSC® cream
- **OTHER:** Sunscreen SPF 50+

## Key facts

- **NCT ID:** NCT01656226
- **Lead sponsor:** ISDIN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01656226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01656226, "Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01656226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*